BioSpace News Archive

Navidea Biopharmaceuticals, Inc. today announced that its Chief Executive Officer, Jed Latkin, will present a corporate overview of the Company at the 11th Annual LD Micro Event, being held December 4-6, 2018 in Bel-Air, California.

Hi-Tech Pharmaceuticals, Inc., today announced the nationwide launch of its PRO IGF-1® dietary supplement.

By stirring crosstalk among skin cells that form the roots of hair, researchers report they have regrown hair strands on damaged skin.

Comprehensive Stroke Evaluation Capabilities Available on Aquilion ONE / GENESIS Edition, to be Showcased at RSNA 2018

Company’s Annual Contributions to American Epilepsy Society Have Totaled More Than $250,000

Increases sensitivity to detect canine bladder and prostate cancers to over 95 percent, enhances implications for human cancer detection

Identifying novel PDAC candidates using a computational approach

MabVax Therapeutics Holdings, Inc. today announced that the Company had entered into an equity purchase agreement with Triton Funds LP, a Delaware limited partnershiP, in which Triton Funds has agreed to purchase up to $1,000,000 of the Company’s to be designated Series P Convertible Preferred Stock, par value of $0.01 per share

Aldeyra Therapeutics, Inc. today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will participate at Citi’s 2018 Global Healthcare Conference on Wednesday, December 5, 2018 at the Lotte New York Palace Hotel in New York, NY.

Turning Point is a clinical-stage precision oncology company developing novel drugs that address treatment resistance